Jeena Sikho Lifecare Limited (JSLL) has announced significant developments in its healthcare operations and investor relations. The company has received prestigious National Accreditation Board for Hospitals & Healthcare Providers (NABH) certifications for its facilities in Agra and Panchkula, while also making its latest earnings call recording available to investors.

NABH Certification Achievement

JSLL has been awarded NABH certification for its hospital facilities in two key locations:

Agra Facility

• Location: B-18, Kamla Nagar, Agra - 282005, Uttar Pradesh
• Certified Service: Panchakarma
• Certification Number: AH-2025-0379
• Validity: Until July 21, 2028

Panchkula Facility

• Location: Plot No. 257-260, Village Raipur, Tehsil Kalka, Panchkula - 134102, Haryana
• Certified Services: Panchakarma, Kayachikitsa, Naturopathy Treatments, Yoga Treatments
• Certification Number: AH-2025-0380
• Validity: Until July 21, 2028

This recognition underscores JSLL's commitment to providing quality healthcare services in accordance with national standards and best practices.

Q1 FY 2025-26 Earnings Conference Call

In a move towards transparency and investor engagement, JSLL has made the audio recording of its Q1 FY 2025-26 earnings conference call available on its website. The call, which took place on August 18, 2025, discussed the company's financial results for the quarter. Investors can access the recording at:

https://jeenasikho.com/wp-content/uploads/2025/08/10035509.mp3

Upcoming Investor Meeting

JSLL's Managing Director, Mr. Manish Grover, is scheduled to attend the Systematix Group – Pharma & Healthcare Conference. The details of the meeting are as follows:

• Date: August 21, 2025
• Venue: The Capital, BKC A Wing No. 603-606, 6th Floor, Plot No. C-70, G Block BKC, Bandra East, Mumbai, Maharashtra 400051
• Mode: Physical Group Meeting
• Time: 10:00 AM

This conference provides an opportunity for investors to gain insights into JSLL's operations and future plans.

These developments highlight JSLL's focus on maintaining high standards in healthcare delivery and its commitment to keeping investors informed about the company's performance and growth strategies.

Jeena Sikho Lifecare Limited, a leading Ayurveda healthcare service provider, has reported strong financial results for the first quarter of fiscal year 2026, demonstrating significant growth across key metrics.

Financial Highlights

Operational Performance

Strategic Developments

• The company added 391 new beds in Q1, expanding its operational capacity.
• Jeena Sikho successfully migrated to the mainboard of NSE and BSE from the NSE Emerge platform in August 2025.
• The company launched a new product, 'Pet Yakrit Pleeha Shuddhi Kit', with several more products in the pipeline.

Management Commentary

Acharya Manish Ji, Managing Director, commented on the results: "We have commenced FY26 on a strong note, delivering robust all-round performance across all key metrics in the first quarter. Our footprint expansion progressed well, with a notable increase in our overall bed count. While the newly added bed capacity is yet to contribute materially to revenues, these investments lay a solid foundation for sustainable growth through the remainder of FY26."

He added, "In FY26, our priority remains on scaling Panchkarma services and driving growth in Medicines & OTC sales. We are confident that our strategic initiatives, combined with our expanded operational capacity, process efficiencies, and innovative service offerings, will continue to drive sustainable growth."

Jeena Sikho Lifecare continues to strengthen its position as a leading player in the Ayurvedic healthcare sector, focusing on holistic health and wellness solutions across India.